Chairman Michael J. Farrell - 13 Nov 2023 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Issuer symbol
RMD
Transactions as of
13 Nov 2023
Net transactions value
-$1,213,694
Form type
4
Filing time
15 Nov 2023, 20:07:45 UTC
Previous filing
17 Oct 2023
Next filing
16 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Tax liability $464,217 -3,233 -0.72% $143.60 446,205 13 Nov 2023 Direct F1
transaction RMD ResMed Common Stock Tax liability $436,243 -3,038 -0.68% $143.60 443,167 13 Nov 2023 Direct F2
transaction RMD ResMed Common Stock Tax liability $313,233 -2,181 -0.49% $143.60 440,986 13 Nov 2023 Direct F3, F4
holding RMD ResMed Common Stock 0 13 Nov 2023 Lisette and Michael Farrell Foundation
holding RMD ResMed Common Stock 4,090 13 Nov 2023 Lisette and Michael Farrell Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/19/2020.
F2 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/18/2021.
F3 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.
F4 Includes 78.152 shares of ResMed stock purchased on October 31, 2023, through the ResMed Employee Stock Purchase Plan.